122 related articles for article (PubMed ID: 33500320)
1. Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer.
Pernar CH; Parmigiani G; Giovannucci EL; Rimm EB; Tyekucheva S; Loda M; Finn SP; Vander Heiden MG; Fiorentino M; Ebot EM; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):751-756. PubMed ID: 33500320
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.
Pernar CH; Ebot EM; Pettersson A; Graff RE; Giunchi F; Ahearn TU; Gonzalez-Feliciano AG; Markt SC; Wilson KM; Stopsack KH; Gazeeva E; Lis RT; Parmigiani G; Rimm EB; Finn SP; Giovannucci EL; Fiorentino M; Mucci LA
Eur Urol; 2019 Jul; 76(1):33-40. PubMed ID: 30301696
[TBL] [Abstract][Full Text] [Related]
3. Vigorous Physical Activity Is Associated with Lower Risk of Metastatic-Lethal Progression in Prostate Cancer and Hypomethylation in the
Dai JY; Wang B; Wang X; Cheng A; Kolb S; Stanford JL; Wright JL
Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):258-264. PubMed ID: 30464020
[TBL] [Abstract][Full Text] [Related]
4. Physical activity and prostate gene expression in men with low-risk prostate cancer.
Magbanua MJ; Richman EL; Sosa EV; Jones LW; Simko J; Shinohara K; Haqq CM; Carroll PR; Chan JM
Cancer Causes Control; 2014 Apr; 25(4):515-23. PubMed ID: 24504435
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer.
Ebot EM; Gerke T; Labbé DP; Sinnott JA; Zadra G; Rider JR; Tyekucheva S; Wilson KM; Kelly RS; Shui IM; Loda M; Kantoff PW; Finn S; Vander Heiden MG; Brown M; Giovannucci EL; Mucci LA
Cancer; 2017 Nov; 123(21):4130-4138. PubMed ID: 28700821
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of physical activity and incident and fatal prostate cancer.
Giovannucci EL; Liu Y; Leitzmann MF; Stampfer MJ; Willett WC
Arch Intern Med; 2005 May; 165(9):1005-10. PubMed ID: 15883238
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of physical activity and prostate cancer in male health professionals.
Giovannucci E; Leitzmann M; Spiegelman D; Rimm EB; Colditz GA; Stampfer MJ; Willett WC
Cancer Res; 1998 Nov; 58(22):5117-22. PubMed ID: 9823321
[TBL] [Abstract][Full Text] [Related]
8. Differential Gene Expression in Prostate Tissue According to Ejaculation Frequency.
Sinnott JA; Brumberg K; Wilson KM; Ebot EM; Giovannucci EL; Mucci LA; Rider JR
Eur Urol; 2018 Nov; 74(5):545-548. PubMed ID: 29784192
[TBL] [Abstract][Full Text] [Related]
9. Physical activity in relation to total, advanced, and fatal prostate cancer.
Moore SC; Peters TM; Ahn J; Park Y; Schatzkin A; Albanes D; Ballard-Barbash R; Hollenbeck A; Leitzmann MF
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2458-66. PubMed ID: 18725512
[TBL] [Abstract][Full Text] [Related]
10. Recreational Physical Activity in Relation to Prostate Cancer-specific Mortality Among Men with Nonmetastatic Prostate Cancer.
Wang Y; Jacobs EJ; Gapstur SM; Maliniak ML; Gansler T; McCullough ML; Stevens VL; Patel AV
Eur Urol; 2017 Dec; 72(6):931-939. PubMed ID: 28711382
[TBL] [Abstract][Full Text] [Related]
11. Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men.
Patel AV; Rodriguez C; Jacobs EJ; Solomon L; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):275-9. PubMed ID: 15668508
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of physical activity and risk of prostate cancer in US physicians.
Liu S; Lee IM; Linson P; Ajani U; Buring JE; Hennekens CH
Int J Epidemiol; 2000 Feb; 29(1):29-35. PubMed ID: 10750600
[TBL] [Abstract][Full Text] [Related]
13. Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.
Myers JS; von Lersner AK; Robbins CJ; Sang QX
PLoS One; 2015; 10(12):e0145322. PubMed ID: 26683658
[TBL] [Abstract][Full Text] [Related]
14. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle.
Thompson M; Lapointe J; Choi YL; Ong DE; Higgins JP; Brooks JD; Pollack JR
Prostate; 2008 Aug; 68(11):1248-56. PubMed ID: 18500686
[TBL] [Abstract][Full Text] [Related]
16. Physical Activity and Prostate Tumor Vessel Morphology: Data from the Health Professionals Follow-up Study.
Van Blarigan EL; Gerstenberger JP; Kenfield SA; Giovannucci EL; Stampfer MJ; Jones LW; Clinton SK; Chan JM; Mucci LA
Cancer Prev Res (Phila); 2015 Oct; 8(10):962-967. PubMed ID: 26276753
[TBL] [Abstract][Full Text] [Related]
17. Association between bivariate expression of key oncogenes and metabolic phenotypes of patients with prostate cancer.
Khodayari Moez E; Pyne S; Dinu I
Comput Biol Med; 2018 Dec; 103():55-63. PubMed ID: 30340213
[TBL] [Abstract][Full Text] [Related]
18. Gene expressional changes in prostate fibroblasts from cancerous tissue.
Reinertsen T; Halgunset J; Viset T; Flatberg A; Haugsmoen LL; Skogseth H
APMIS; 2012 Jul; 120(7):558-71. PubMed ID: 22716211
[TBL] [Abstract][Full Text] [Related]
19. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
[TBL] [Abstract][Full Text] [Related]
20. Regular aspirin use and gene expression profiles in prostate cancer patients.
Stopsack KH; Ebot EM; Downer MK; Gerke TA; Rider JR; Kantoff PW; Mucci LA
Cancer Causes Control; 2018 Aug; 29(8):775-784. PubMed ID: 29915914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
